Target intelligence / Profile preview

Neuronal PAS domain protein 2 (NPAS2)

Target
NPAS2
Molecular classification
Transcription factor, Basic helix-loop-helix PAS domain family protein, Hemeprotein
01

Overview

NPAS2 is a **transcription factor of the bHLH-PAS family** that regulates circadian rhythms, sleep–wake cycles, and diverse physiological processes in mammals. It forms heterodimers with BMAL1, binding E-box DNA sequences in core clock gene promoters to control their expression through well-characterized feedback loops[1][2][3][4][5][6][7]. NPAS2 is distinguished from its paralogue CLOCK by unique expression patterns and regulatory features, including gas (carbon monoxide)- and heme-based sensing, which directly influences its DNA binding and transcriptional activity. NPAS2’s functions extend from central nervous system regulation to metabolic control in the liver, modulation of neurotransmitter systems, and response to cellular stress and DNA damage. Dysregulation or genetic variation of NPAS2 is associated with disease, especially cancer, sleep and mood disorders, and cardiovascular conditions. NPAS2 is under investigation as both a therapeutic target and a biomarker for certain disease states owing to its central role in circadian biology.

Other names
Member of PAS protein 4MOP4PASD4bHLHe9basic helix–loop–helix-PAS protein MOP4class E basic helix–loop–helix protein 9PAS domain-containing protein 4neuronal PAS2
02

Mechanism of action

Drugs or compounds acting on NPAS2 would generally modulate circadian clock function, metabolic regulation, or related transcriptional programs; the mechanism could involve impacting NPAS2-BMAL1 heterodimer activity, heme-binding regulation, and gas (CO)-responsive transcriptional activity[2][4].

03

Biological functions

Regulation of circadian rhythmTranscriptional control of clock genes (e.g., PER1/2/3, CRY1/2)Regulation of sleep homeostasisControl of metabolic pathways (e.g., in liver)DNA damage response and cell cycle regulationModulation of neurotransmission (e.g., GABAergic signaling)Behavioral regulation (e.g., anxiety-like behaviors)
04

Disease associations

Cancer (especially breast cancer, lung cancer, non-Hodgkin's lymphoma)Sleep disturbances and psychiatric disordersNeurodegenerative diseasesCardiovascular diseaseCerebrovascular diseasePotential role in metabolic disease and wound healing
05

Safety considerations

Potential therapeutic challenges include off-target effects linked to global circadian disruption (e.g., sleep disturbance, metabolic dysregulation, psychiatric symptoms), as NPAS2 is widely expressed across tissues controlling daily rhythms[3][4].Additional concerns may arise from impaired wound healing, neuronal, or cardiovascular function.
06

Interacting drugs

Direct pharmacological modulators of NPAS2 are not well established in clinical practice or literature; however, NPAS2 is considered a promising druggable target[4]. Some experimental modulators may regulate circadian rhythm, but no specific drugs directly targeting NPAS2 are widely referenced.
07

Biomarkers

NPAS2 gene expression and sequence variants are emerging biomarkers in cancer (predictive of survival and outcomes) and circadian rhythm-related disease states[5][4].Differential NPAS2 expression has biomarker utility in breast/lung cancer and sleep disorders.

Beyond the preview

Go deeper on Neuronal PAS domain protein 2 (NPAS2).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Neuronal PAS domain protein 2 (NPAS2).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call